Planned Solutions’s Clovis Oncology, Inc. CLVS Stock Holding History

Planned Solutions’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,000	Closed	-$5K	–	452
2020 Q4	$5K	Buy	+1,000	New	+$5.06K	﹤0.01%	394

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Planned Solutions's CLVS Position: Q1 2021 in Review

Planned Solutions sold out of Clovis Oncology, Inc. (CLVS) in Q1 2021, closing a stake of 1,000 shares — an estimated $5K sold.

Planned Solutions first reported a position in CLVS in Q4 2020 and held it in 1 quarter. The position peaked at $5K in Q4 2020. 165 funds tracked by Wall St. Rank hold CLVS as of Q1 2021.

Planned Solutions reported no remaining Clovis Oncology, Inc. position as of Q1 2021 after selling out during the quarter.
Planned Solutions sold 1,000 Clovis Oncology, Inc. shares in Q1 2021, an estimated $5K.
Planned Solutions first reported a position in Clovis Oncology, Inc. in Q4 2020 and held it in 1 quarter.
Planned Solutions's Clovis Oncology, Inc. position peaked at $5K in Q4 2020.
165 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2021.

Based on Planned Solutions's 13F filing for Q1 2021, filed 29 Apr 2021.